Development Of A Novel Drug For Chronic And Infected Wounds
Funder
National Health and Medical Research Council
Funding Amount
$482,362.00
Summary
Chronic wounds affect more than 9 million people worldwide and demand for wound care is increasing. The annual cost to healthcare systems in the US and Australia in treating such wounds is US$25 billion and AU$3 billion, respectively, and there is urgent need for more effective approaches.
Targeting Collagen Cross-linking To Improve Scar Appearance
Funder
National Health and Medical Research Council
Funding Amount
$873,305.00
Summary
Scarring is a significant problem after injury, and the life-long appearance of scar can be very detrimental to peoples’ wellbeing, both psychological and physical. This work will develop a new drug to improve scar appearance. The drug is likely to be effective even after scar has formed, making it possible to improve scarring in many people. This will improve the quality of life for people after injury.
A Non-invasive Fluid Status Monitoring Device For Heart Failure
Funder
National Health and Medical Research Council
Funding Amount
$360,715.00
Summary
Both acute decompensated heart failure (ADHF) and chronic kidney disease (CKD) are characterised by fluid overload. A device to detect this fluid overload in patients at an early stage has the potential to reduce the need for hospitalisation and initiate more timely and aggressive intervention. A prototype device has already been developed and our aim is to further improve on this device and advance to a commercial product.